PD-L1 was found to be significantly associated with overall survival in breast cancer, kidney renal clear cell carcinoma, LIHC, ovarian cancer (OV), pancreatic ductal adenocarcinoma (PAAD), sarcoma, TGCT, THYM, UCEC, LGG and SKCM (Figure S1). This evidence concerns the gene CD274 and breast carcinoma.